Amgen pointed to encouraging interim MariTide data and says the drug is moving quickly toward late-stage testing ahead of its Q3 earnings.
Recap by typeshit. Full story at Kalkine Media.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Healio
Speaking at OMED, Frye names melanotan as the riskiest, citing ED cases of priapism and rhabdomyolysis, and describes the BPC-157 and TB-500 Wolverine Stack.
A short social share with no study or source named, flagging possible nutrient shortfalls for people on weight loss shots.
Loading…